178 related articles for article (PubMed ID: 27099961)
1. Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.
Nellis G; Metsvaht T; Varendi H; Lass J; Duncan J; Nunn AJ; Turner MA; Lutsar I
Paediatr Drugs; 2016 Jun; 18(3):221-30. PubMed ID: 27099961
[TBL] [Abstract][Full Text] [Related]
2. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
[TBL] [Abstract][Full Text] [Related]
3. The potentially harmful excipients in prescribed medications in a Neonatal Intensive Care Unit in Kosovo and available safer alternatives.
Koshi B; Grapci AD; Nebija D; Selmani PB; Morina R; Crcarevska MS; Dodov MG; Raichki RS
Turk J Pediatr; 2022; 64(1):49-58. PubMed ID: 35286030
[TBL] [Abstract][Full Text] [Related]
4. A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia.
Sviestina I; Mozgis D
Eur J Hosp Pharm; 2018 Jul; 25(4):176-182. PubMed ID: 31157015
[TBL] [Abstract][Full Text] [Related]
5. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan.
Saito J; Nadatani N; Setoguchi M; Nakao M; Kimura H; Sameshima M; Kobayashi K; Matsumoto H; Yoshikawa N; Yokoyama T; Takahashi H; Suenaga M; Watanabe R; Imai K; Obara M; Hashimoto M; Yamamoto K; Fujiwara N; Sakata W; Nagai H; Enokihara T; Katayama S; Takahashi Y; Araki M; Iino K; Akiyama N; Katsu H; Fushimi K; Takeda T; Torimoto M; Kishi R; Mitsuya N; Kihara R; Hasegawa Y; Hamada Y; Kimura T; Wada M; Tanzawa A; Yamatani A
J Pharm Health Care Sci; 2021 Jul; 7(1):23. PubMed ID: 34193299
[TBL] [Abstract][Full Text] [Related]
6. Exposure to potentially harmful excipients in medications among neonates at a state hospital in Malaysia.
Wong SW; Chew SP; Abdul Aziz SA; Mohamed Shah N
Drug Dev Ind Pharm; 2024 Mar; ():1-9. PubMed ID: 38459761
[TBL] [Abstract][Full Text] [Related]
7. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
Valeur KS; Hertel SA; Lundstrøm KE; Holst H
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
[TBL] [Abstract][Full Text] [Related]
8. Safe excipient exposure in neonates and small children - protocol for the SEEN project.
Valeur KS; Hertel SA; Lundstrøm KE; Holst H
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157063
[TBL] [Abstract][Full Text] [Related]
9. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
Shehab N; Lewis CL; Streetman DD; Donn SM
Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
[TBL] [Abstract][Full Text] [Related]
10. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates.
Sridharan K; Hasan HM; Al Jufairi M; Al Daylami A; Al Ansari E; Qader AM; Pasha SAA
Expert Opin Drug Saf; 2020 Dec; 19(12):1625-1640. PubMed ID: 32767900
[TBL] [Abstract][Full Text] [Related]
11. Hospitalised neonates in Estonia commonly receive potentially harmful excipients.
Lass J; Naelapää K; Shah U; Käär R; Varendi H; Turner MA; Lutsar I
BMC Pediatr; 2012 Aug; 12():136. PubMed ID: 22931304
[TBL] [Abstract][Full Text] [Related]
12. Toxic excipients in medications for neonates in Brazil.
Souza A; Santos D; Fonseca S; Medeiros M; Batista L; Turner M; Coelho H
Eur J Pediatr; 2014 Jul; 173(7):935-45. PubMed ID: 24500397
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
Nasrollahi S; Meera NK; Boregowda S
Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
[TBL] [Abstract][Full Text] [Related]
14. Harmful excipients in medicines for neonates in Spain.
Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.
Saito J; Nakamura H; Akabane M; Yamatani A
Ther Innov Regul Sci; 2024 Mar; 58(2):316-335. PubMed ID: 38055156
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of ethanol and other potentially harmful excipients in pediatric oral medicines: survey of community pharmacies in a Nigerian City.
Soremekun R; Ogbuefi I; Aderemi-Williams R
BMC Res Notes; 2019 Jul; 12(1):460. PubMed ID: 31349864
[TBL] [Abstract][Full Text] [Related]
17. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
18. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
Ursino MG; Poluzzi E; Caramella C; De Ponti F
Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
[TBL] [Abstract][Full Text] [Related]
19. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
[TBL] [Abstract][Full Text] [Related]
20. [Presence of excipients in pharmaceutical products in 3 sources of therapeutic information].
Altimiras J; Nieto-Hernández T; Buitrago F
Aten Primaria; 1996 Sep; 18(4):190-3. PubMed ID: 8963000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
